Chugai Pharmaceutical Co. Ltd.

06/11/2021 | Press release | Distributed by Public on 06/11/2021 02:03

Chugai Files New Drug Application in Japan for Faricimab, the First Bispecific Antibody in Ophthalmology for Diabetic Macular Edema and Neovascular Age-related Macular Degeneration